We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » United Therapeutics Wants Answers After FDA Denies Its PAH Drug
United Therapeutics Wants Answers After FDA Denies Its PAH Drug
October 26, 2012
United Therapeutics (UT) is hoping to get some answers from an end-of-review meeting on why the FDA rejected its oral treprostinil diethanolamine extended-release tablets for pulmonary arterial hypertension (PAH).